Quantification and parametric imaging of renal cortical blood flow in vivo based on Patlak graphical analysis. Patlak graphical analysis was applied to quantify renal cortical blood flow with N-13 ammonia and dynamic positron emission tomography. Measurements were made in a swine model of kidney transplantation with a wide range of normal and abnormal renal blood flows (N = 57 studies) and in 20 healthy human volunteers (N = 45 studies). Estimates of renal cortical blood flow by the Patlak method were compared to those from a two-compartment model for N-13 ammonia. In addition, estimates of renal cortical blood flow by the N-l3 ammonia PET approach were compared in 10 normal human volunteers to estimates by the metabolically inert, freely diffusible 0-15 water and a one-compartment model. Patlak graphical analysis estimates of renal cortical blood flow correlated linearly with the standard two-compartment model in pigs (y = -0.05 + I.Olx, r = 0.99) and in humans (y = 0.57 + 0.88x, r = 0.93). Estimates of renal cortical blood flow by 0-15 water in human volunteers were also linearly correlated with those by N-13 ammonia and the Patlak graphical analysis (y = 0.71 + 0,84x, r = 0.86). Renal cortical blood flow estimates were highly reproducible both with N-13 ammonia and 0-15 water measurements in humans. It is concluded that the Patlak graphical analysis with N-l3 ammonia dynamic positron emission tomographic imaging renders accurate and reproducible estimates of renal cortical blood flow. Moreover, the graphical analysis approach is 1,000 times faster than the standard model fitting approach and suitable for generating parametric images of renal blood flow in the clinical setting.
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Experimental studies have shown renal blood flow (RBF) to be heterogeneous under physiologic, ischemic and hyperemic conditions. This heterogeneity has been demonstrated in animal models of clinically important conditions such as trauma, hemorrhage and shock [1] . In addition to the major renal arteries and veins and their related subbranches, there are several distinct microvascular networks: the glomerular and the cortical peritubular microcirculations and microcirculatory systems that supply and drain the medulla. Methods for measuring RBF have not been widely applied clinically because of their invasiveness, technical complexity [2] , and limited clinical availability. Additionally, no clear correlation between the titative estimates of RBF per unit mass of renal tissue in humans is of potential investigative and clinical utility. For example, abnormalities in RBF resulting from advanced arterial hypertension, acute cortical necrosis, acute tubular necrosis, acute rejection of a kidney transplant or cyclosporine toxicity could potentially be defined more quantitatively and, thus, objectively.
Positron emission tomography (PET) permits quantitative volumetric measurements of tissue radioactivity concentrations from cross sectional images. Chen et al [4] demonstrated in dog experiments that N-13 ammonia dynamic imaging with PET provides accurate estimates of renal cortical blood flow (RCBF) . They estimated RCBF by fitting the regional cortical time-activity curves to a two-compartment model for N-13 ammonia. The estimates by this approach correlated well with independent measurements by the radiolabeled microsphere and arterial sample technique. N-13 ammonia has longer tissue retention times and offers better count statistics than other PET flow tracers such as 0-15 water. However, retention of N-13 ammonia in tissue may be sensitive to metabolic alterations. Further, its extraction fraction declines with increasing RBF. Although validated in dogs, the validity of the N-13 ammonia PET approach for quantifying RCBF remains to be established in humans. This is because species related differences may alter the relationship between the first-pass retention fraction of N-13 ammonia and RBF. Moreover, quantification of RCBF with the two-compartment model is tedious, time consuming and, consequently, clinically impractical. This limitation could be overcome with a more simple and computationally efficient graphical analysis method [5, 6] .
The purpose of this study was therefore to answer the The study design includes studies in animals and in humans. The animal studies served to test the validity of the graphical analysis approach over a wide range of RCBF's as well as of normal and abnormal conditions. The validity of the measurement approach was then tested in humans and compared to an independent measurement of RCBF with the previously established 0-15 water approach [7] .
Animals
Ten young adult female Duroc farm pigs (body weight ranging 25 to 30 kg) were studied repeatedly under different experimental conditions. These included normal-baseline (8 pigs, 8 studies), acute tubular necrosis in autotransplanted kidneys submitted to different durations of warm ischemia [120 mm, 150 mm, 180 mm (8 pigs, 23 studies)], acute rejection of renal heterotransplants (2 pigs, 5 studies), renal hypertrophy (4 pigs, 9 studies) and acute as well as chronic cyclosporine toxicity (6 pigs, 12 studies). Pathologic conditions were confirmed by biopsy. A total of 57 studies (average 6 studies per animal) with N-I 3 ammonia and dynamic PET were performed. Details of renal transplantation of the pig model have been reported by Yanaga et al [8] . These standardized conditions for hemodynamics and hydration were applied to all PET studies.
Humans
Twenty healthy human subjects (16 male, 4 female, mean age 29 years, ranging 18 to 54 years) were studied. None had a history of prior renal disease. Entrance criteria included normal heart rate, blood pressure, blood cell count, serum creatinine level, plasma sodium and urine analysis. A total of 45 PET measurements were performed in the 20 human volunteers. The first ten subjects had repeat measurements after a 60 minute delay (to allow for N-13 decay, T112 9.8 mm) to test the reproducibility of the method. Ten subjects were studied with both N-13 ammonia and 0-15 water. In this group, five subjects had repeat 0-15 water studies to evaluate the reproducibility of the 0-15 water RCBF method. 0-15 water studies were separated by 15 minutes (0-15 T112 = 2 mm).
All volunteers were prepared by drinking 500 ml water 60 minutes prior to the study and were instructed to empty the bladder immediately prior to the PET procedure.
The animal and human studies were approved by the UCLA Animal Research Committee and the UCLA Human Subject Protection Committee. Maintenance and care of the pigs was in compliance with the National Institutes of Health guidelines for use of laboratory animals. All human subjects signed written consent forms alter the procedures had been fully explained.
Radiopharmaceuticals
The animals were intravenously injected over 30 seconds with N-13 ammonia (20 mCi diluted in 2 to 8 ml saline) while acquisition of the serial transaxial tomographic images was started. The human volunteers were injected with 20 mCi N-l3 ammonia and (in ten subjects) 30 mCi 0-15 water over 30 seconds into a peripheral vein while acquisition of the serial transaxial tomographic images was started. Both tracers were produced and synthesized as reported previously [9, 10] .
PET imaging
After obtaining a 30-minute blank scan and a 20-minute transmission image for photon attenuation correction, both N-l3 ammonia and 0-15 water emission images were acquired on a Siemens/CTI Model 93 1/08-12 tomograph. This device records 15 image planes simultaneously. The axial field of view is 10.8 cm. Ultrasound guidance was used for adequate position of the kidneys in the tomograph's field of view. All subjects were imaged in the supine position.
For N-13 ammonia, the acquisition protocol included twelve 10 second, six 20 second and four 240 second frames in both humans and animals. For the 0-15 water studies in humans, twelve 10 second, four 30 second and one 60 second frame were acquired. Cross sectional images for all studies were reconstructed employing a Shepp-Logan filter with a cut-off frequency of 0.30 mm', yielding an in plane spatial resolution at the center of the plane of approximately 10 mm full-width half-maximum.
Input function
Serial arterial blood samples of 1 ml each were drawn every 10 seconds for the first two minutes alter tracer injection to measure directly the N-13 ammonia and 0-15 water arterial input functions. N-13 and 0-15 whole blood activity concentrations in pre-weighed tubes were measured in a well counter. In addition, for the N-13 ammonia studies, three whole blood samples (1 ml each) were drawn at 0.65 0.06, 1.35 0.08 and 2 0.05 minutes alter tracer injection to determine the timedependent distribution of N-l3 label between ammonia and its metabolites in the arterial input function as described previously [11] . These distribution measures were used to correct the arterial input function for the true amount of N-13 ammonia delivered to the kidneys.
Conversion factor between image data and well counter data A cylinder phantom containing Ge-68/Ga-68 solution was scanned alter each study in order to determine a conversion factor between image data in units of counts/pixel/sec and well counter data in units counts/mL/sec. This conversion factor was derived as follows: a known aliquot from the solution in the phantom was removed and its activity concentration measured in a well counter (Turn-Key Microsphere Measurement System, MICRAD). The calibration factor was derived from the ratio of counts/mllsec measured in the well counter to the counts/pixel/sec recorded from the cylinder with the PET scanner.
Data analysis and applied corrections Circular regions of interest (ROl) were drawn over the renal cortex using summed images (for example summing the dynamically acquired images one to twelve corresponding to time zero to two mm post-injection). The ROl's encompassed the entire transaxial area of the cortex (one region per slice). The central area, including the renal medulla and collecting system, was omitted. The ROl's were then copied to the dynamic image set.
Counts/pixel obtained from these ROl's were converted to counts/pixellmin by normalizing for the acquisition time of each dynamically acquired image. These values were then converted to equivalent well counter counts/mllmin using the calibration dt D
where RBF is the renal blood flow in mllmin/g, Qf and Qt are the total N-13 activity (counts/mi/mm) in compartments C1 and C2, respectively, K1 the forward rate constant in ml/min/g from Qf to Qt, k2 the tubular clearance constant in min' from Qt to the tubular lumen, D the distribution volume in mug of N-13 ammonia within the free space (0.8 mllg [4] ), Ca(t) the arterial activity of N-13 ammonia in counts/minim!, p the specific gravity of blood (1.05 g/ml) and t the time in minutes. Thus, RCBF can be calculated by solving these differential equations describing the two-compartment model and by fitting to the measured renal tissue time-activity curves. This approach has been validated for RCBF ranging 1 to 6.5 mllmin/g against independent microsphere measurements [4] .
For the graphical analysis approach the Patlak plot of the multiple-time renal tissue uptake is defined as the ratio of the total renal tissue concentration at the times of sampling to the plasma concentration (Ca) at the respective times (t) versus the ratio of the arterial plasma concentration-time integral to the plasma concentration (Ca), as described by equation 7 (listed below). This equation is derived in the following way: If k2 is assumed to be 0 and equations 1 and 2 are integrated, then At time t after tracer injection, the N-13 activity concentration in renal tissue ROl [Qi(t)] equals the sum of the radioactivity of free N-13 ammonia in the freely diffusible pool Qf(t), the radioactivity of N-13 ammonia metabolites in the bound pool Qt(t) and the arterial concentration of the radiopharmaceutical (AB). This relationship is expressed by
where V,, is the vascular volume and AB the arterial N-13 activity uncorrected for metabolite concentrations. Note the difference between Ca(t), defined as metabolite corrected N-13 activity and AB, defined as non-metabo!ite corrected N-l3 activity.
Substituting Qf(t) and Qt(t) in equation 5 by equations 3 and 4, expressing the time integral of Qf(t) for that of Ca(t), and including the relationship from equation 1 that
factor. All time-activity curves were corrected for dead time of the scanner [12] .
Partial volume effects result in less than 100% recovery of tissue activity in structures measuring less than about twice the full-width hall-maximum image resolution value [13] . These activity losses can be corrected if the recovery coefficient is known. We employed an approach developed in our laboratory for the calculation of the recovery coefficients in the animal studies [14] . This approach is based on cross-sectional profile fitting analysis. In brief, each circular ROl drawn over the renal cortex was divided in four subsectors. The estimates of activity thicknesses, together with four known subsector contour thicknesses, were used to derive four subsector recovery coefficients. These subsector recovery coefficients were then combined into one recovery coefficient for the renal cortical ROl. In the human studies estimates for the recovery coefficients were based on ultrasound measurements of the renal cortical thickness.
The true tissue activity concentration in the renal cortex was calculated as the observed radiotracer concentration divided by the recovery coefficient.
Patlak graphical analysis for the quantification of RBF The Patlak approach is a graphical method for estimating the unidirectional blood-to-renal tissue transfer constant from renal time-activity uptake data. The approach assumes unidirectional transport and trapping of N-13 ammonia from blood into tissue.
The total N-13 activity observed in a region of interest represents the sum of activities in two functional compartments: compartment 1 (C1) contains the free N-13 ammonia in renal tissue and extravascular space, while compartment 2 (C2) Ct -
derived from dog kidney studies [4] . RBF can then be calcu-Simplifying equation 12 by expressing lated using equations 9 and 10, by first estimating the slope K1
of the straight portion of the graph, with Qf(t)/Ca(t) as the
vertical y-axis and fCa(1)dT/Ca(t) as the horizontal x-axis [15] . one derives N-13 ammonia is secreted into the renal tubules. Therefore, N-13 activity will proceed into the tubular lumen and leave the Ct = Ca(t) ® pke_kt (eq. 14) region of interest assigned to the renal cortex. Activity concentrations will decline, and the assumption of a unidirectional where the asterisk (®) indicates the mathematical operation of transport or k2 to be zero is no longer valid. Hence, the based on the time-activity curves is therefore critical. Consetj quently, only the kinetic data recorded from 40 to 90 seconds after tracer injection were used in the Patlak approach. In 'Ctdt is measured by PET fort = t1 tot1÷1 for i = 1. . 12 and addition, effects of including earlier or later recorded kinetic Ca(t) 0 pke_kt is calculated using the one-compartment model and the arterial input function for a given p and renal data on the Patlak estimates of RCBF were evaluated. blood flow. RCBF was then estimated by using equation 15 to fit II the assumptions are valid, then the fit to the kinetic data the measured renal time-activity curves. will be linear. The slope represents K, and the y-intercept will Several methods are available to correct for intravascular depend on the distribution volume (VD), on renal blood flow activity within the tissue ROl before finally estimating RCBF. (RBF), on the forward rate constant from Qf to Qt (K1) and on One employs blood pool images obtained with 0-15 or C-li the vascular volume (V). Again, the regression line will be carbon monoxide and subtraction of these images from the 0-15 linear only if k2 is indeed 0 for the time of measurement.
water images. A second approach adds a third parameter to the The 0-15 water technique to quantify RBF one-compartment model to estimate the blood pool. In the The theory for the measurement of blood flow using the inert present study, a third parameter for calculation of the blood freely diffusible 0-15 water was described for the kidney by pool activity [vascular blood pool in renal tissue (RBV) obInaba et al [7] , and for myocardium by Bergmann et al [16] and served in the analyzed ROl] was added to the 0-15 water model lida et al [17] . The general principles have been proposed by to correct for intravascular activity within tissue ROl's [20, 21] .
Kety [18] . Kuten et al observed a high correlation of RBF This approach was chosen in this study because direct meaestimates by 0-15 water and estimates by independent micro-surements of renal intravascular volume with 0-15 carbon sphere RBF measurements [19] . The input function was derived from peripheral arterial blood sampling. Its inherent problem is the time delay between the aortic and the peripheral (such as, brachial) peak activity. To minimize errors potentially introduced by the time delays between the input function and the tissue response, the peak activity of the arterial input function was adjusted to the time of the aortic peak activity. The latter was determined from a circular ROl (size 6 3 pixel) assigned to the abdominal aorta.
The RCBF value for one kidney was calculated as the average value for all analyzed ROl per kidney.
Parametric imaging Parametric images of RCBF using N-l3 ammonia and Patlak graphical analysis were generated by applying equations 7 and 9 to each pixel.
Statistical analysis
All results are expressed as mean standard deviation (SD). Linear least-squares regression was performed to correlate RCBF calculated with the two-compartment model and Patlak graphical analysis for N-13 ammonia measurements in humans and animals. For evaluation of mean differences in the reproducibility for N-13 ammonia and 0-15 water RCBF studies as well as differences between N-l3 ammonia and 0-15 water RCBF measurements, the paired t-test was used. A P value < 0.05 was considered significant. Results N-13 ammonia renal imaging and Pat/ak graphical analysis N-13 ammonia yielded high quality cross-sectional images of the kidneys with PET imaging. The image quality was preserved even when RCBF was markedly altered as was the case in the pig experiments (Fig. 3) . As shown in Figure 4 , the Patlak plots of the time-activity curves for all analyzed ROl were consistently linear for the selected sampling times. If earlier (such as 20 to 30 seconds post-injection) recorded renal tissue points were included for the Patlak graphical analysis, the calculated RCBF values did not correlate as well with model fitting results, because that part of the data is not expected to be linear. In addition, if more (such as >90 seconds post-injection) renal tissue points were included, the curve of the Patlak plot became nonlinear, indicating that the definition (such as the tubular clearance k2 is negligible) for Patlak graphical analysis may no longer be satisfied. For k2 ranging from 0 min' to 0.2 min1 after 110 seconds post-injection the change of the RCBF estimates was less than 5%. It was similar at both high and low RCBF values. 0-15 water studies 0-15 water dynamic PET renal images compared to N-13 ammonia renal PET images have lower image quality, such as lower kidney to background ratio. However, both kidneys are depicted clearly in normal human volunteers (Fig. 7) . Comparison of RCBF estimates derived from N-13 ammonia and 0-15 water studies
As shown in Figure 8 , the estimates of RCBF for both radiopharmaceuticals in human normals were linearly correlated. The differences between the N-13 ammonia and the 0-15 water RCBF estimates were statistically insignificant. A P value of 0.48 for Patlak graphical analysis RCBF estimates and a P value of 0.23 for the two-compartment model fitting RCBF estimates compared to 0-15 water RCBF estimates were observed.
Reproducibility of RCBF measurements Heart rate and blood pressure remained stable in all subjects during the PET measurements. Repeat measurements of RCBF with N-l3 ammonia and dynamic PET in nine volunteers revealed for Patlak graphical analysis individual interstudy differences of 0.31 0.18 mllmin/g or 6.6% 3.7% (P = 0.91) and for model fitting 0.22 0.15 ml/min/g or 5.0% 3.4%(P = 0.62). Absolute individual interstudy differences for 0-15 water measurements in five volunteers were 0.11 0.07 ml/min/g or 2.2%
1.3% (P = 0.12). The interstudy differences of the RCBF estimates within each individual approach were insignificant.
N-13 ammonia metabolites
The results of N-13 ammonia metabolite measurements are shown in Table 1 . The mean amount of N-13 labeled ammonia metabolites as fraction of the total N-13 activity at two minutes post injection was 7% 5% for human normals while in pigs it was 10.5% 2%.
Thickness of the renal cortex
Circumferential profile fitting analysis revealed the following average estimates for renal cortical thickness in the pig experiments: 11.8 0.7 mm for normal kidneys, 13. Figure 9 , parametric images of RCBF contain less noise and therefore an improved kidney to background ratio as compared to dynamic renal images.
Parametric imaging As shown in

Computation time
The computation time for the Patlak approach to estimate RCBF in a 15 plane dynamic study is two minutes. This is -50% faster as compared to approximately four to five minutes for the model fitting method.
Discussion
The results of this study indicate that the kinetics of N-13 ammonia in the kidney following intravenous injection satisfy the requirements of Patlak graphical analysis. Therefore, Patlak graphical analysis can be applied to quantify RCBF. Moreover, Patlak graphical analysis produces RCBF estimates comparable to those obtained with the two-compartment model method for N-l3 ammonia. Further, the excellent agreement of the N-13 ammonia estimates of RCBF with those by the metabolically inert and less flow dependent 0-15 water method supports the validity of the N-13 ammonia technique in humans, which, as demonstrated by repeat measurements, is highly reproducible.
Comparison of RCBF estimates derived from Patlak graphical analysis and the two-compartment model for N-13 ammonia
The slightly better correlation between Patlak graphical analysis and model fitting in the pig experiments (Fig. 5 ) as compared to the correlation in the human studies (Fig. 6 ) may have been due to the narrow range of RCBF's in humans and better count statistics in the animal experiments.
Quantfi cation of RCBF with dynamic PET and N-13 ammonia or 0-15 water and its limitations in the present study
The PET technique for measurements of RBF has been successfully employed by several groups [4, 7, 22, 23] measurements of RBF in eight human subjects [7] . The advantage of 0-15 water as RBF agent is that it is metabolically inert and completely extracted in renal tissue. In contrast, N-13 ammonia is not metabolically inert and its retention fraction declines as RBF increases above the normal range [4] . For the latter reason it is necessary to include the relationship between RBF and retention fraction. This relationship is mathematically expressed by equations 9 and 10. Both equations are incorporated in the Patlak and the two-compartment model fitting approach. Its limitation is the derivation from animal studies because microsphere studies cannot be performed in humans. However, the good agreement between RCBF estimates obtained by both, the 0-15 water and N-13 ammonia PET ap- 0-15 water emission images. Inaccuracies in the subtraction process may cause errors in the estimation of RBF [25] . For the present study, a third parameter was added to the one-compartment model for 0-15 water in order to correct for blood volume effects. Including the blood volume term in the fitting procedure was found by others to be superior to the subtraction method, both in terms of accuracy and precision [21] . The correction approach may also have contributed to the good agreement between N-13 ammonia and 0-15 water RCBF estimates observed in this study. [26] as well as in this study indicate that there are species differences in the blood concentrations of N-13 labeled ammonia metabolites within the two minutes post injection time period, such as 19% 16% for dogs and 10.5% 2% for pigs. These observations suggest the need for metabolite correction when N-13 ammonia is utilized for RBF studies in animals.
Minimization of invasiveness to obtain the input function Determination of the arterial input function from serial blood samples, as performed in this study, adds complexity to routine clinical procedures. However, alternative methods include sampling from the arterial part of an arterio-venous shunt or dynamic PET measurements of the abdominal aortic activity for the non-invasive determination of the arterial input function [27] .
Recove,y coefficients for renal cortex Corrections for partial-volume effects (such as renal cortex recovery coefficient) are relatively straightforward in the normal human kidney where cortex and medulla are identifiable sonographically. However, in human kidney transplants, anatomical measurements based on ultrasound do not provide appropriate measures of the renal cortex thickness. In such conditions, use of cross-sectional profile fitting analysis or constant recovery coefficients may be preferable. The results Fig. 9 . Parametric cross-sectional image of N-13 ammonia indicated RCBF, generated from a study in a healthy human volunteer (P04092). [29] based on pig experiments indicate the need for such a compromise for non-physiological conditions like acute tubular necrosis, acute rejection or renal hypertrophy, when accurate anatomical measurements for the object size are not available. The recovery coefficient can differ significantly (for example, normal cortex value of -0.65 to -0.75 compared to acute tubular necrosis value of -0.75 to -0.85). Since this variability affects Patlak graphical analysis and model fitting results in the same way, this is not a limitation specific to the Patlak method.
A
Parametric images of N-13 ammonia indicated RCBF Parametric PET imaging of RCBF is an advantageous approach particularly for the clinical setting. It provides dynamically acquired geographic information about RCBF compressed in a single renal PET image. In addition, the unspecific background noise is suppressed rendering improved image quality compared to dynamic renal PET images.
RCBF in human normals measured by dynamic PET compared to the Xenon-133 washout method In the renal cortex blood flow averages 4 to 6 ml/min/g as indicated from measurements in different animal species and human studies [28] . The RCBF values measured with PET in human normals in this study are comparable to those by the Xenon-133 washout method [29, 30] listed in Table 2 . The slightly higher RCBF values reported by Ladefoged and Peder- son [30] may be explained by the small age range of the volunteers and possible differences in the sodium balance.
Clinical RCBF studies based on dynamic PET PET offers assessment of RBF without urine collection, as required in standard clearance techniques. Therefore, PET is applicable to the oliguric state. RBF can be measured noninvasively within a reasonable time as for example 30 minutes. RBF analysis can be performed on data acquired dynamically over three to five minutes. Repeat measurements can be performed within a short time period. Information about compartmental RBF is provided, not obtained from gamma camera renal studies or clearance methods. Finally, the radiotracer can be administered intravenously.
Conclusion
Patlak graphical analysis applied to N-13 ammonia dynamic PET for quantifying RCBF in vivo in humans is an accurate, reproducible and computationally fast method for investigative and clinical applications. N-l3 ammonia is a valid RCBF indicator in humans compared to the 0-15 water technique.
Quantification of RCBF with dynamic PET is highly reproducible. Parametric imaging of N-l3 ammonia indicated RCBF is an advanced imaging approach for the clinical setting.
